Characterization of Proteins by Size-Exclusion Chromatography Coupled to Multi-Angle Light Scattering (SEC-MALS)
June 20th, 2019
61.2K views
This protocol describes the combination of size exclusion chromatography with multi-angle light scattering (SEC-MALS) for absolute characterization of proteins and complexes in solution. SEC-MALS determines the molecular weight and size of pure proteins, native oligomers, heterocomplexes and modified proteins such as glycoproteins.
Overview
This protocol describes the combination of size exclusion chromatography with multi-angle light scattering (SEC-MALS) for absolute characterization of proteins and complexes in solution. SEC-MALS determines the molecular weight and size of pure proteins, native oligomers, heterocomplexes and modified proteins such as glycoproteins.
Key Study Components
Area of Science
- Biochemistry
- Protein characterization
- Analytical chemistry
Background
- SEC-MALS is a quantitative method for determining molecular weight and size.
- It can identify oligomers and complexes, including glycoproteins.
- This method does not rely on molecular standards.
- Applicable to a wide range of macromolecules.
Purpose of Study
- To provide a reliable method for characterizing proteins in solution.
- To facilitate the analysis of complex biological samples.
- To enhance understanding of protein interactions and structures.
Methods Used
- Preparation of SEC-MALS system and buffers.
- Filtration and flushing of the system to ensure cleanliness.
- Sample preparation and injection into the SEC-MALS system.
- Data collection and analysis using MALS software.
Main Results
- Successful characterization of proteins and complexes.
- Verification of system cleanliness and sample integrity.
- Accurate determination of molecular weights and sizes.
- Identification of oligomers and complexes in samples.
Conclusions
- SEC-MALS is an effective method for protein characterization.
- It provides absolute measurements without reliance on standards.
- This technique can be applied to a variety of biological macromolecules.
Frequently Asked Questions
What is SEC-MALS?
SEC-MALS is a method that combines size exclusion chromatography with multi-angle light scattering to characterize proteins and complexes.
Why is SEC-MALS important?
It allows for absolute characterization of proteins without reliance on molecular standards, making it highly reliable.
What types of samples can be analyzed with SEC-MALS?
SEC-MALS can analyze a wide range of samples including proteins, glycoproteins, and other macromolecules.
How do you ensure system cleanliness before running samples?
System cleanliness is ensured by filtering buffers and performing blank injections to check for particles.
What parameters are set in the MALS software?
Parameters include sample and mobile phase settings, flow rates, and specific coefficients for the proteins being analyzed.
Executive Industry Relevance
SEC-MALS provides absolute molecular weight and size characterization of proteins and complexes in solution, eliminating reliance on molecular standards and reducing analytical uncertainty in early discovery. This capability supports target validation by confirming the biophysical state of therapeutic candidates, including oligomers, aggregates, and modified species such as glycoproteins. By delivering quantitative, conformation-independent data, SEC-MALS enhances predictive confidence in protein behavior, informing go/no-go decisions and reducing late-stage biological risk in biopharma R&D pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Confirms homogeneity and molecular weight of protein monomers, oligomers, and complexes, enabling accurate assessment of therapeutic target integrity.
- Operational Value: Distinguishes between static and dynamic protein equilibria, clarifying whether observed species represent stable assemblies or transient interactions.
- Predictive Value: Detects aggregates and heterogeneous populations early, supporting risk-adjusted prioritization of candidates before downstream investment.
Screening & Assay Development
- Scientific Value: Enables analysis of modified proteins such as glycoproteins and detergent-solubilized membrane proteins, expanding the range of tractable targets for screening campaigns.
- Operational Value: Provides quantitative, absolute molecular weight measurements at each elution volume, facilitating assay standardization and reproducibility across laboratories.
- Platform Utility: Generates reference data for BSA and other standards that can be saved as methods for future SEC-MALS runs, promoting enterprise-wide reuse and consistency.
Translational & Preclinical Research
- Translational Continuity: Supports characterization of protein complexes and modified forms relevant to disease mechanisms, bridging discovery and preclinical validation.
- Mechanistic De-risking: Determines whether observed species arise from covalent modification, non-specific aggregation, or specific oligomerization, clarifying mechanism of action and formulation risks.
- Preclinical Alignment: Delivers solution-based size and conformation data that complement structural techniques like cryo-EM or NMR, enabling integrated target profiling.
Pipeline & Workflow Integration
SEC-MALS functions as a foundational analytical step in the discovery continuum, positioned after protein expression and purification but before functional assays or structural determination, ensuring that only properly characterized molecules advance in the pipeline.
- Discovery Biology: Validates the oligomeric state and monodispersity of purified proteins, reducing false positives in target engagement and signaling assays.
- Screening: Ensures that protein ligands or analytes used in screening assays are well-defined and homogeneous, improving data quality and hit confirmation rates.
- Analytics: Delivers weight-average molar mass, size, and mass fraction outputs that enable direct comparison of protein variants, mutants, or formulation conditions.
- Translational Research: Characterizes glycoproteins and membrane protein complexes in near-native conditions, supporting biomarker relevance and mechanism-of-action studies.
- Enterprise Reuse: Allows laboratories to save validated methods (e.g., BSA-based) for broad application across projects, reducing method development time and increasing analytical throughput.
Operational & Enterprise Impact
- Scientific Value: Provides absolute, conformation-independent molecular weight determination, increasing confidence in target identity and reducing mechanistic ambiguity.
- Operational Value: Enables system suitability checks via blank injections and particle monitoring, ensuring reproducible runs and minimizing failed experiments due to contamination.
- Strategic Value: Supports early detection of aggregation and heterogeneity, informing formulation development and reducing risk of late-stage failure due to instability.
- Portfolio Impact: Enables data-driven go/no-go decisions based on biophysical quality, improving capital efficiency and advancing only well-characterized candidates.
Implementation Considerations
- Requires expertise in protein purification, buffer preparation, and SEC-MALS system operation, including MALS detector alignment and normalization procedures.
- Dependent on access to a calibrated SEC-MALS system with low-noise light scattering and refractive index detectors, and appropriate columns (e.g., 200 Å pore size for BSA).
- Necessitates rigorous sample and buffer filtration (0.1–0.2 μm) and system flushing to eliminate particulates that can scatter light and compromise data quality.
- Requires accurate input of protein-specific parameters such as dn/dc and UV extinction coefficient in the MALS software for valid molecular weight calculations.
- Limited by the need for monodisperse, soluble samples; precipitates or large aggregates must be removed via centrifugation or filtration prior to injection to avoid column clogging and signal artifacts.
Biopharma FAQs
Why does molecular weight accuracy matter for target validation?
SEC-MALS provides absolute molecular weight measurements independent of elution time or molecular standards, ensuring accurate assessment of protein oligomers and complexes. This accuracy is critical for confirming the biophysical identity of therapeutic targets and avoiding misinterpretation due to column interactions or non-ideal protein behavior.
How does system cleanliness impact data reliability in SEC-MALS?
Particulates in the system or sample generate false light scattering signals that can be mistaken for protein aggregates or high-molecular-weight species. The protocol emphasizes buffer filtration, column flushing, and blank injections to achieve a stable baseline with low noise (<50–100 μV peak-to-peak) and RI signal stability (<1×10⁻⁷ RIU), ensuring that observed peaks reflect true protein species.
What quantitative outputs does SEC-MALS provide for protein characterization?
SEC-MALS delivers weight-average molar mass, radius of gyration, and mass fraction for each eluting peak, enabling quantification of monomer, dimer, and higher-order species. These outputs allow researchers to assess sample homogeneity and detect aggregation or complex formation under native conditions.
Why are replication requirements important for SEC-MALS in collaborative projects?
Replicate runs confirm that system suitability, sample preparation, and data acquisition are consistent across users and sessions, which is essential for generating reproducible data in multi-lab or multi-project environments. The protocol supports this by allowing saved methods (e.g., BSA-based) to carry over normalization and band broadening parameters, promoting standardization.
What analytical capabilities are required before implementing SEC-MALS for protein analysis?
Successful implementation requires a properly calibrated SEC-MALS system with MALS and RI detectors, knowledge of the protein’s dn/dc and extinction coefficient, and expertise in software-based peak alignment, normalization, and baseline correction. Users must also be trained in sample preparation, filtration, and system suitability testing to ensure data integrity.
